BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alhamad EH, Shaik SA, Idrees MM, Alanezi MO, Isnani AC. Outcome measures of the 6 minute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosis. BMC Pulm Med 2010;10:42. [PMID: 20696064 DOI: 10.1186/1471-2466-10-42] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Marcellis RG, Lenssen AF, de Vries J, Drent M. Reduced muscle strength, exercise intolerance and disabling symptoms in sarcoidosis: . Current Opinion in Pulmonary Medicine 2013;19:524-30. [DOI: 10.1097/mcp.0b013e328363f563] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ors F, Gumus S, Aydogan M, Sari S, Verim S, Deniz O. HRCT findings of pulmonary sarcoidosis; relation to pulmonary function tests. Multidiscip Respir Med 2013;8:8. [PMID: 23384173 DOI: 10.1186/2049-6958-8-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
3 Yagi K, Asakura T, Namkoong H, Suzuki S, Asami T, Okamori S, Kusumoto T, Funatsu Y, Kamata H, Nishimura T, Ishii M, Betsuyaku T, Hasegawa N. Association between six-minute walk test parameters and the health-related quality of life in patients with pulmonary Mycobacterium avium complex disease. BMC Pulm Med 2018;18:114. [PMID: 30005658 DOI: 10.1186/s12890-018-0686-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Hsieh MH, Fang YF, Chung FT, Lee CS, Chang YC, Liu YZ, Wu CH, Lin HC. Distance-saturation product of the 6-minute walk test predicts mortality of patients with non-cystic fibrosis bronchiectasis. J Thorac Dis 2017;9:3168-76. [PMID: 29221293 DOI: 10.21037/jtd.2017.08.53] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
5 Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, Lee AL, Camillo CA, Troosters T, Spruit MA, Carlin BW, Wanger J, Pepin V, Saey D, Pitta F, Kaminsky DA, Mccormack MC, Macintyre N, Culver BH, Sciurba FC, Revill SM, Delafosse V, Holland AE. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 2014;44:1447-78. [DOI: 10.1183/09031936.00150414] [Cited by in Crossref: 343] [Cited by in F6Publishing: 313] [Article Influence: 42.9] [Reference Citation Analysis]
6 Huitema MP, Mathijssen H, Mager JJ, Snijder RJ, Grutters JC, Post MC. Sarcoidosis-Associated Pulmonary Hypertension. Semin Respir Crit Care Med 2020;41:659-72. [DOI: 10.1055/s-0040-1713615] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Lopes AJ, de Menezes SL, Dias CM, de Oliveira JF, Mainenti MR, Guimarães FS. Comparison between cardiopulmonary exercise testing parameters and computed tomography findings in patients with thoracic sarcoidosis. Lung 2011;189:425-31. [PMID: 21858420 DOI: 10.1007/s00408-011-9316-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
8 Someya F, Mugii N. Limitations to the 6-minute walk test in dermatomyositis with interstitial lung disease in comparison with idiopathic interstitial pneumonia. Clin Med Insights Circ Respir Pulm Med 2013;7:1-6. [PMID: 23400027 DOI: 10.4137/CCRPM.S10764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Andrianopoulos V, Wouters EF, Pinto-Plata VM, Vanfleteren LE, Bakke PS, Franssen FM, Agusti A, MacNee W, Rennard SI, Tal-Singer R, Vogiatzis I, Vestbo J, Celli BR, Spruit MA. Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study. Respir Med 2015;109:1138-46. [PMID: 26143282 DOI: 10.1016/j.rmed.2015.06.013] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
10 Lingner H, Buhr-schinner H, Hummel S, van der Meyden J, Grosshennig A, Nowik D, Schultz K. Short-Term Effects of a Multimodal 3-Week Inpatient Pulmonary Rehabilitation Programme for Patients with Sarcoidosis: The ProKaSaRe Study. Respiration 2018;95:343-53. [DOI: 10.1159/000486964] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
11 Baughman RP, Engel PJ, Nathan S. Pulmonary Hypertension in Sarcoidosis. Clin Chest Med 2015;36:703-14. [PMID: 26593143 DOI: 10.1016/j.ccm.2015.08.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
12 Kaptan Ozen D, Mutlu B, Kocakaya D, Turan B, Sert Sekerci S, Ceyhan B, Kepez A, Erdogan O. The effect of global longitudinal strain on ımpaired six-minute walk test performance in patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2020;37:66-73. [PMID: 33093770 DOI: 10.36141/svdld.v37i1.8802] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44:1428-1446. [PMID: 25359355 DOI: 10.1183/09031936.00150314] [Cited by in Crossref: 790] [Cited by in F6Publishing: 766] [Article Influence: 98.8] [Reference Citation Analysis]
14 Gupta R, Baughman RP, Nathan SD, Wells AU, Kouranos V, Alhamad EH, Culver DA, Barney J, Carmona EM, Cordova FC, Huitema M, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Price LC, Wort SJ, Shlobin OA. The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry. Respiratory Medicine 2022;196:106801. [DOI: 10.1016/j.rmed.2022.106801] [Reference Citation Analysis]
15 Alhamad EH, Cosgrove GP. Interstitial lung disease: the initial approach. Med Clin North Am 2011;95:1071-93. [PMID: 22032428 DOI: 10.1016/j.mcna.2011.08.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
16 de Boer S, Kolbe J, Wilsher ML. Comparison of the modified shuttle walk test and cardiopulmonary exercise test in sarcoidosis: MSWT in sarcoidosis. Respirology 2014;19:604-7. [DOI: 10.1111/resp.12276] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
17 Martusewicz-Boros MM, Boros PW, Wiatr E, Zych J, Kempisty A, Kram M, Piotrowska-Kownacka D, Wesołowski S, Baughman RP, Roszkowski-Sliż K. Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction?: A case-control study. Medicine (Baltimore) 2019;98:e18037. [PMID: 31764823 DOI: 10.1097/MD.0000000000018037] [Reference Citation Analysis]
18 Thunold RF, Løkke A, Cohen AL, Ole H, Bendstrup E. Patient reported outcome measures (PROMs) in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2017;34:2-17. [PMID: 32476819 DOI: 10.36141/svdld.v34i1.5760] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Lingner H, Großhennig A, Flunkert K, Buhr-Schinner H, Heitmann R, Tönnesmann U, van der Meyden J, Schultz K. ProKaSaRe Study Protocol: A Prospective Multicenter Study of Pulmonary Rehabilitation of Patients With Sarcoidosis. JMIR Res Protoc 2015;4:e134. [PMID: 26679102 DOI: 10.2196/resprot.4948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Huitema MP, Grutters JC, Rensing BJWM, Reesink HJ, Post MC. Pulmonary hypertension complicating pulmonary sarcoidosis. Neth Heart J 2016;24:390-9. [PMID: 27194118 DOI: 10.1007/s12471-016-0847-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
21 Vancampfort D, Probst M, Stubbs B, Soundy A, De Herdt A, De Hert M. Associations between expiratory spirometry parameters and limitations in daily life activities in patients with schizophrenia. General Hospital Psychiatry 2014;36:172-6. [DOI: 10.1016/j.genhosppsych.2013.11.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
22 Storm FA, Cesareo A, Reni G, Biffi E. Wearable Inertial Sensors to Assess Gait during the 6-Minute Walk Test: A Systematic Review. Sensors (Basel) 2020;20:E2660. [PMID: 32384806 DOI: 10.3390/s20092660] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]